House
RoundsGuidelinesCalculatorsPricing
Sign inCreate account→
House

Citation-backed clinical intelligence for verified physicians.

Product

  • Rounds
  • Guidelines
  • Calculators
  • Pricing

Company

  • About
  • Editorial Policy

© 2026 House

For verified, licensed physicians. Not a substitute for clinical judgement.

Back to guidelines
Psychiatry · MOHFW

Alcohol use disorder

MOHFW
B
Source:MoHFW Standard Treatment Guideline — Management of Alcohol Dependence (2021)IPS Substance Use Disorders CPG (2021)NICE CG115 (2021)ASAM National Practice Guideline (2021)
Verified Apr 2026
Ask House about this guideline

Red Flags

  • Severe alcohol withdrawal (delirium tremens — confusion, agitation, autonomic instability, hallucinations) — admit for IV benzodiazepine, thiamine, supportive care; mortality 5–15% untreated[1]
  • Alcohol withdrawal seizure or status epilepticus — IV benzodiazepine; admit; investigate other causes (intoxication, electrolytes, head injury)[1]
  • Wernicke's encephalopathy (confusion, ophthalmoplegia, ataxia) — emergency parenteral thiamine 500 mg IV TDS × 2–3 days BEFORE any glucose; do not wait for full triad[1]
  • Cirrhosis with alcohol use — variceal bleeding, ascites, encephalopathy, hepatocellular carcinoma; hepatology referral; absolute alcohol cessation[1]

First-line treatment

Interventions

  • Brief intervention for hazardous use[1]
    5As (assess, advise, agree, assist, arrange) for AUDIT 8–15; structured discussion of risks, units, sensible-drinking limits; arrange follow-up
  • Setting of care for detoxification[1]
    Outpatient detox for mild–moderate dependence with adequate support and no complications. Inpatient detox for severe dependence (>30 units/day), prior complicated withdrawal, comorbidity, pregnancy, or unstable housing
  • Psychosocial interventions[1]
    Motivational interviewing, cognitive behavioural therapy, relapse-prevention skills, contingency management; mutual aid (AA, SMART Recovery); family involvement; treat comorbid mental health

First-line drug therapy

DrugClassAdultPaediatricNotes
Chlordiazepoxide (long-acting benzodiazepine)[1]Benzodiazepine — long-acting20–30 mg PO QDS day 1, taper over 5–10 days. Symptom-triggered with CIWA-Ar; front-loading 50 mg every 1–2 h until symptoms controlled—First-line for alcohol withdrawal; long-acting smooths taper; switch to lorazepam if hepatic impairment or elderly
Lorazepam (short-acting; hepatic impairment)[1]Benzodiazepine — short-acting1–2 mg PO/IM/IV every 4–6 h, symptom-triggered taper—Preferred in cirrhosis or elderly because no active metabolite; IV/IM available for severe withdrawal or DT
Thiamine (parenteral then oral)[1]B-vitaminWernicke prophylaxis: 250 mg IM/IV daily × 3–5 days. Suspected Wernicke: 500 mg IV TDS × 2–3 days, then 250 mg/day. Long-term: thiamine 100 mg PO TDS for ≥3 months—Give BEFORE any IV glucose to avoid precipitating Wernicke encephalopathy; oral absorption poor in dependence — start parenteral
Acamprosate[1]Glutamate-modulating agent666 mg PO TDS (333 mg TDS if <60 kg)—Maintenance abstinence after detox; renal dose adjustment; start within 5 days of last drink and continue ≥6 months; combine with psychosocial therapy
Naltrexone (oral or IM long-acting)[1]Opioid antagonistOral 50 mg PO daily; IM 380 mg every 4 weeks—Reduces craving and heavy drinking days; contraindicated with current opioid use, hepatic failure; check LFTs; warn about reduced opioid analgesic response in emergency
Disulfiram[1]Aldehyde dehydrogenase inhibitor500 mg PO daily × 1–2 weeks then 250 mg daily—Aversive — causes flushing, nausea, hypotension if alcohol consumed; supervised administration improves adherence; contraindicated in cardiac disease, psychosis, pregnancy
Baclofen (selected liver disease)[1]GABA-B agonist5–10 mg PO TDS start, titrate to 30–80 mg/day—Useful in alcohol use with cirrhosis — does not require hepatic metabolism; sedation at higher dose; potential for misuse and seizure on abrupt withdrawal
Chlordiazepoxide (long-acting benzodiazepine)[1]
Benzodiazepine — long-acting
Adult
20–30 mg PO QDS day 1, taper over 5–10 days. Symptom-triggered with CIWA-Ar; front-loading 50 mg every 1–2 h until symptoms controlled
Paediatric
—
First-line for alcohol withdrawal; long-acting smooths taper; switch to lorazepam if hepatic impairment or elderly
Lorazepam (short-acting; hepatic impairment)[1]
Benzodiazepine — short-acting
Adult
1–2 mg PO/IM/IV every 4–6 h, symptom-triggered taper
Paediatric
—
Preferred in cirrhosis or elderly because no active metabolite; IV/IM available for severe withdrawal or DT
Thiamine (parenteral then oral)[1]
B-vitamin
Adult
Wernicke prophylaxis: 250 mg IM/IV daily × 3–5 days. Suspected Wernicke: 500 mg IV TDS × 2–3 days, then 250 mg/day. Long-term: thiamine 100 mg PO TDS for ≥3 months
Paediatric
—
Give BEFORE any IV glucose to avoid precipitating Wernicke encephalopathy; oral absorption poor in dependence — start parenteral
Acamprosate[1]
Glutamate-modulating agent
Adult
666 mg PO TDS (333 mg TDS if <60 kg)
Paediatric
—
Maintenance abstinence after detox; renal dose adjustment; start within 5 days of last drink and continue ≥6 months; combine with psychosocial therapy
Naltrexone (oral or IM long-acting)[1]
Opioid antagonist
Adult
Oral 50 mg PO daily; IM 380 mg every 4 weeks
Paediatric
—
Reduces craving and heavy drinking days; contraindicated with current opioid use, hepatic failure; check LFTs; warn about reduced opioid analgesic response in emergency
Disulfiram[1]
Aldehyde dehydrogenase inhibitor
Adult
500 mg PO daily × 1–2 weeks then 250 mg daily
Paediatric
—
Aversive — causes flushing, nausea, hypotension if alcohol consumed; supervised administration improves adherence; contraindicated in cardiac disease, psychosis, pregnancy
Baclofen (selected liver disease)[1]
GABA-B agonist
Adult
5–10 mg PO TDS start, titrate to 30–80 mg/day
Paediatric
—
Useful in alcohol use with cirrhosis — does not require hepatic metabolism; sedation at higher dose; potential for misuse and seizure on abrupt withdrawal

Safety-net

  1. Stopping alcohol abruptly after heavy long-term use can cause fits and life-threatening withdrawal — never go cold turkey without medical supervision[1]
  2. Take prescribed thiamine without missing doses for at least 3 months — protects against irreversible brain damage[1]
  3. Tell every prescriber, dentist, and emergency clinician about disulfiram or naltrexone — interactions matter for analgesics, anaesthetics, and alcohol-containing medications[1]

Referral criteria

  • Severe alcohol dependence requiring inpatient detox (DT history, seizures, severe comorbidity)Specialist addiction unit or psychiatric inpatient[1]
  • Wernicke encephalopathy or alcoholic hepatitisEmergency department; gastroenterology / neurology[1]
  • Pregnancy with alcohol dependenceJoint addiction and obstetric service; consider fetal alcohol spectrum disorder counselling[1]
  • Comorbid severe mental illness or homelessnessMulti-agency team — psychiatry, addiction, social work[1]

Clinical summary

Diagnosis and stepwise management of alcohol use disorder including detoxification, thiamine prophylaxis, and relapse-prevention pharmacotherapy.

References

  1. 1.MoHFW Standard Treatment Guideline — Management of Alcohol Dependence (2021); IPS Substance Use Disorders CPG; NICE CG115; ASAM National Practice Guideline (2021)

On this page

  • Red flags
  • First-line treatment
  • Safety-net
  • Referral
  • References